Show item record

dc.contributor.authorLamarre, V.
dc.contributor.authorGilbert, Nicolas
dc.contributor.authorRousseau, C.
dc.contributor.authorGyorkos, Theresa W.
dc.contributor.authorFraser, William
dc.date.accessioned2018-11-05T17:35:38Z
dc.date.availableNO_RESTRICTIONfr
dc.date.available2018-11-05T17:35:38Z
dc.date.issued2015-12
dc.identifier.urihttp://hdl.handle.net/1866/21042
dc.publisherCambridge University Pressfr
dc.rightsCe document est mis à disposition selon les termes de la Licence Creative Commons Paternité 4.0 International. / This work is licensed under a Creative Commons Attribution 4.0 International License.
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectCytomegalovirusfr
dc.subjectInfectious disease epidemiologyfr
dc.subjectPregnancyfr
dc.subjectPreventionfr
dc.subjectSerologyfr
dc.titleSeroconversion for cytomegalovirus infection in a cohort of pregnant women in Québec, 2010–2013fr
dc.typeArticlefr
dc.contributor.affiliationUniversité de Montréal. École de santé publiquefr
dc.identifier.doi10.1017/S0950268815003167
dcterms.abstractCytomegalovirus (CMV) is the leading cause of congenital infection and non-genetic sensorineural hearing loss in children. There are no recent data on the incidence of CMV infection during pregnancy in Canada. This present study was undertaken to determine the seroprevalence of CMV IgG antibodies and the rate of seroconversion in a cohort of pregnant women in the province of Québec, Canada. We used serum samples and questionnaire data collected as part of the 3D Pregnancy and Birth Cohort Study (2010–2013) conducted in Québec, Canada. CMV IgG antibodies were determined in serum samples collected at the first and third trimesters. Associations between independent variables and seroprevalence were assessed using logistic regression, and associations with seroconversions, by Poisson regression. Of 1938 pregnant women tested, 40·4% were seropositive for CMV at baseline. Previous CMV infection was associated with: working as a daycare educator, lower education, lower income, having had children, first language other than French or English, and being born outside Canada or the United States. Of the 1122 initially seronegative women, 24 (2·1%) seroconverted between their first and third trimesters. The seroconversion rate was 1·4 [95% confidence interval (CI) 0·9–2·1]/ 10 000 person-days at risk or 3·9 (95% CI 2·5–5·9)/100 pregnancies (assuming a 280-day gestation). The high proportion of pregnant women susceptible to CMV infection (nearly 60%) and the subsequent rate of seroconversion are of concern.fr
dcterms.isPartOfurn:ISSN:0950-2688fr
dcterms.isPartOfurn:ISSN:1469-4409fr
dcterms.languageengfr
UdeM.ReferenceFournieParDeposant10.1017/S0950268815003167fr
UdeM.VersionRioxxVersion publiée / Version of Recordfr
oaire.citationTitleEpidemiology and infection
oaire.citationVolume144
oaire.citationIssue8
oaire.citationStartPage1701
oaire.citationEndPage1709


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show item record

Ce document est mis à disposition selon les termes de la Licence Creative Commons Paternité 4.0 International. / This work is licensed under a Creative Commons Attribution 4.0 International License.
Usage rights : Ce document est mis à disposition selon les termes de la Licence Creative Commons Paternité 4.0 International. / This work is licensed under a Creative Commons Attribution 4.0 International License.